Molecular mechanisms of EPHB4 pathogenesis – towards new treatment development for lymphatic anomalies

Awardee: Silvia Martin Almedina

Institution: St. George’s University of London

Awarded: $25,000

Funding Period: September 1, 2022 - August 31, 2023

Previous
Previous

Multi-organ Gene Therapy for Bloom Syndrome

Next
Next

Analysis of a new therapeutic approach to inhibit osteolysis in Gorham-Stout Disease